Your browser doesn't support javascript.
loading
High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial.
Cook, Gordon; Williams, Cathy; Brown, Julia M; Cairns, David A; Cavenagh, Jamie; Snowden, John A; Ashcroft, A John; Fletcher, Marie; Parrish, Chris; Yong, Kwee; Cavet, Jim; Hunter, Hanna; Bird, Jenny M; Chalmers, Anna; O'Connor, Sheila; Drayson, Mark T; Morris, Treen C M.
Affiliation
  • Cook G; St James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, UK. Electronic address: g.cook@leeds.ac.uk.
  • Williams C; Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Brown JM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Cavenagh J; Department of Haematology, Barts and The London NHS Trust, London, UK.
  • Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust and University of Sheffield, Sheffield, UK.
  • Ashcroft AJ; Mid Yorkshire Hospitals NHS Trust, Wakefield, UK.
  • Fletcher M; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Parrish C; St James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, UK.
  • Yong K; Department of Haematology, University College Hospital, London, UK.
  • Cavet J; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.
  • Hunter H; Department of Haematology, Plymouth Hospitals NHS Trust, Plymouth, UK.
  • Bird JM; Department of Haematology, United Bristol Hospitals NHS Trust, Bristol, UK.
  • Chalmers A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • O'Connor S; Haematology Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, UK.
  • Drayson MT; University of Birmingham, Birmingham, UK.
  • Morris TC; Queen's University, Belfast, UK.
Lancet Oncol ; 15(8): 874-85, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24948586
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salvage Therapy / Antineoplastic Agents, Alkylating / Cyclophosphamide / Stem Cell Transplantation / Consolidation Chemotherapy / Melphalan / Multiple Myeloma Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salvage Therapy / Antineoplastic Agents, Alkylating / Cyclophosphamide / Stem Cell Transplantation / Consolidation Chemotherapy / Melphalan / Multiple Myeloma Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article